期刊文献+

鼠伤寒沙门菌pagC启动子的克隆与活性分析 被引量:7

Cloning and Functional Analysis of Promoter pagC from Attenuated Salmonella typhimurium
下载PDF
导出
摘要 从鼠伤寒沙门菌中克隆出pagC启动子 (PpagC) ,构建体内激活的表达质粒pZW ,插入庚型肝炎病毒 (HGV)NS3基因 ,构建出表达质粒pZWNS3。以其转化减毒鼠伤寒沙门菌SL72 0 7,观察PpagC 的启动活性。结果表明 :Mg2 +可抑制PpagC 的启动活性 ,Mg2 +浓度小于50mmol L时培养的重组菌经SDS PAGE和Westernblot检测能高水平表达HGVNS3蛋白。Mg2 +浓度升至 50mmol L时 ,NS3蛋白表达量明显降低。收集以 50mmol LMg2 +的培养基扩增的重组菌 ,灌胃接种C57小鼠 ,检测小鼠的血清抗体、T细胞增殖和CTL反应。结果显示PpagC是一个强的宿主体内激活的启动子 ,为构建以伤寒沙门氏菌为载体的高效免疫口服疫苗提供了一个新的途径。 This study describes the cloning and function of promoter pagC(P pagC) from Salmonella typhimurium. The expression plasmid containing the in vivo-inducible promoter pagC and HGV-NS3 gene was introduced into the attenuated Salmonella typhimurium SL7207 to investigate the function of P pagC. The expressed HGV-NS3 protein was detectable by SDS-PAGE and Western blotting in the recombinant bacteria in the presence of low concentration of Mg 2+ (<50mmol/L). When the concentration of Mg 2+ reached to 50mmol/L, the amount of expressed HGV-NS3 was decreased significantly. The recombinant bacteria were multiplied in LB medium containing 50mmol/L of Mg 2+ and used as a DNA vaccine to orally inoculate C57 mice for three times. The results of serum antibodies, T lymphocyte proliferative response and cytotoxic T lymphocyte response of immunized mice showed that the oral vaccine could iuduce strong humoral and cellular immune responses in mice, which indicates that the P pagC is a strong in vivo-inducible promoter and can be used in attenuated Salmonella typhimurium to construct an effective oral vaccine.
出处 《微生物学报》 CAS CSCD 北大核心 2003年第3期308-314,共7页 Acta Microbiologica Sinica
基金 国家自然科学基金资助项目 ( 30 1 70 5 1 4 )
关键词 鼠伤寒沙门菌 pagC启动子 克隆 活性 镁离子 庚型肝炎病毒 表达质粒 Salmonella typhimurium, Promoter, pagC, Mg2+, Hepatitis G virus
  • 相关文献

参考文献14

  • 1朱分禄,任浩,宋燕斌,戚中田.庚型肝炎病毒NS3蛋白在大肠杆菌中的表达[J].中华微生物学和免疫学杂志,1999,19(6):475-478. 被引量:8
  • 2赵平,赵兰娟,曹洁,洪海燕,戚中田.信号肽和辅助性T细胞表位增强HBV核心抗原DNA疫苗诱导的免疫应答[J].生物化学与生物物理学报,2002,34(3):341-346. 被引量:12
  • 3Medina E, Paglia P, Rohde M, et al. Modulation of host immune responses stimulated by Solmonella vaccine carrier strains by using different promoters to drive the expression of the recombinant antigen. Eur J Immunol, 2000, 30:768 - 777.
  • 4Dunstan S J, Simmons C P, Strugnell R A. Use of in vivo-regulated promoters to deliver antigens from attenuated Salmonella enterica var. Typhimurium. Infect Immun, 1999, 67(10):5133 - 5141.
  • 5Qi Z T, Ren H, Zhu F L, et al. Construction and identification of a single stranded cDNA clone containing full-length genome of hepatitis G virus. Ross Gastroenterol Zh, 2001, (2):46 - 56.
  • 6Kier L K, Weppleman R M, Ames B N. Regulation of nonspecific acid phosphatase in Salmonella : phoN and phoP genes. J Bacteriol, 1979, 138:155 - 161.
  • 7Miller S I, Kurkal A M, Mekalanos J J. A two-component regulatory system (phoP phoQ)controls Salmonella typhimurium virulence. Proc Natl Acad Sci USA, 1989, 86:5054 - 5058.
  • 8Groisman E A, Parra-Lopez C, Salcedo M, et al. Resistance to host antimicrobial peptides is necessary for Salmonella virulence. Proc Natl Acad Sci USA, 1992, 89(24):11939- 11943.
  • 9Pulkkinen W S, Miller S I. A Salmonella typhimurium virulence protein is similar to a yersinia enterocolitica invasion protein and a bacteriophage lambda outer membrane protein. J Bacterial, 1991, 173(1):86 - 93.
  • 10Garcia Vescovi E, Soncini F C, Groisman E A. Mg2+ as an extracellular signal:environmental regulation of Salmonella virulence. Cell, 1996, 84:165- 174.

二级参考文献25

  • 1Wang H L,J Infect Dis,1997年,175卷,1229页
  • 2Wu R R,J Infect Dis,1997年,175卷,168页
  • 3汪兴太,中华微生物学和免疫学杂志,1997年,17卷,157页
  • 4Shao L,Biochem Biophys Res Commun,1996年,228卷,785页
  • 5Linnen J,Science,1996年,271卷,5248期,505页
  • 6Chisari FV. Cytotoxic T cells and viral hepatitis. J Clin Invest,1997, 99 (7): 1472-1477
  • 7Bocher WO, Galun E, Marcus H, Daudi N, Terkieltaub D, Shouvai D, Lohr HF et al. Reduced hepatitis B virus surface antigenspecific Thl helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trimera mouse. Hepatology,2000, 31(2):480-487.
  • 8Yang JY, Jin J, Kong YY, Wei J, Zhang ZC, Li GD, Wang Y et al. Purification and characterization of recombinant hepatitis B virus surface antigen SS1 expressed in Pichia Pastoris. Acta Biochim Biophys Sin, 2000, 32:503-508
  • 9Livingston BD, Alexander J, Crimi C, Oseroff C, Celis E, Daly K, Guidotti LG et al. Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans.J Immunol, 1999,162(5) : 3088-3095
  • 10Pol S, Michel ML, Brechot C. Immune therapy of hepatitis B virus chronic infection.Hepatology, 2000, 31(2): 548-549

共引文献18

同被引文献32

  • 1Clump JA, Luby SP, Mintz ED. The global burden of typhoid fever[ J]. Bull World Health Organ ,2004,82 ( 5 ) :346 - 353.
  • 2Ochiai RL, Wang X, von Seidlein L, et al, Salmonella paratyphi A rates, Asia [ J ]. Emerg Infect Dis, 2005,11 ( 11 ) : 1764 - 1766.
  • 3Yang HH, Gong J, Zhang J, et al. An outbreak of Salmonella paratyphi A in a boarding school: a community-acquired enteric fever and carriage investigation [ J ]. Epidemiol Infect, 2010,138(12) :1765 - 1774.
  • 4Woods CW, Murdoch DR, Zimmerman MD, et al. Emergence of Salmonella enterica serotype paratyphi A as a major cause of enteric fever in Kathmandu, Nepal [ J ]. Trans R Soc Trop Med Hyg ,2006 ,100 ( 11 ) : 1063 - 1067.
  • 5Connor BA, Schwartz E. Typhoid and paratyphoid fever in travelers[J]. Lancet Infect Dis,2005,5 ( 10 ) :623 - 628.
  • 6Meltzer E, Sadik C, Schwartz E. Enteric fever in Israeli travelers : a nationwide study [J]. J Travel Med, 2005,12 ( 5 ) : 275 - 281.
  • 7Verma S, Thakur S, Kanga A, et al. Emerging Salmonella paratyphi A enteric fever and changing trends in antimicrobial resistance pattern of Salmonella in Shimla [ J ]. Indian J Med Microbiol,2010,28( 1 ) :51 -53.
  • 8Molloy A, Nair S, Cooke FJ, et al. First report of Salmonella enterica serotype paratyphi a azithromycin resistance leading to treatment failure. 2010[J]. J Clin Microbiol,2010, 48 (12) : 4655 - 4657.
  • 9Guzman CA, Borsutzky S, Griot-Wenk M, et al. Vaccines against typhoid fever [J]. Vaccine, 2006,24 ( 18 ) : 3804 - 3811.
  • 10Levine MM, Ferreccio C, Black RE, et al. Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica serovar paratyphi B [J]. Clin Infect Dis, 2007,45 Suppl 1 :S24 -28.

引证文献7

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部